Skip to content

Current Debt at other companies

Eli Lilly logo
Eli LillyLLY
$4B-0.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.46B+25.6%
AbbVie logo
AbbVieABBV
$0-100%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.03B+3,224%
Viatris logo
ViatrisVTRS
$1.93B+22,619%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$191.2M+57.4%
Gross profit$176.5M+58.0%
Operating income-$63.4M-11.2%
Net income-$64.5M-8.6%
EPS (diluted)-$1.26-3.3%

Balance sheet

See full
Cash & equivalents$305.1M+1.4%
Total debt$219.9M+4.1%
Total equity$54.6M+2.6%
Total assets$713.6M+19.6%

Cash flow

See full
Operating cash flow-$20.7M+52.3%
CapEx$121.0K-64.2%
Free cash flow-$20.8M+52.4%

Valuation

See full
Market cap$12.89B+52.0%
Enterprise value$12.81B+52.9%
P/S18.2×-1.4×

Profitability

See full
Gross margin92.6%+1.1pp
Operating margin-24.4%-9.3pp
Net margin-26.6%-9.8pp
FCF margin-10.2%-3.9pp

Returns & leverage

See full
Return on equity-349.4%+109pp
Debt / equity+0.1×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Axsome Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axsome Therapeutics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axsome Therapeutics's current debt?
Axsome Therapeutics (AXSM) reported current debt of $70M in Q1 2026.
What does current debt mean?
The amount of long-term debt that must be paid back within one year.
How do you interpret current debt?
Higher values indicate increased near-term liquidity pressure, while lower values suggest a more manageable debt maturity profile.
How does current debt compare across companies?
Highly comparable across all capital-intensive industries.